Overview

Early Diabetes Intervention Program

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This is an evaluation of the effect of acarbose to delay worsening of fasting glucose control in early Type 2 diabetes mellitus.
Phase:
Phase 4
Details
Lead Sponsor:
Indiana University School of Medicine
Collaborator:
Bayer
Treatments:
Acarbose